TABLE 3.

Metastatic ULMS—patient, tumor, treatment, outcome variables

Variable	Metastatic (n = 192)
Patient variables
Age (median years, range)	57 (29–89)
Race (white/other)	149/43
Previous HRT (yes/no) (unknown = 3)	50/139
Previous pregnancy (yes/no) (unknown = 18)	147/27
Synchronous local tumors (yes/no)	104/88
Primary	69
Recurrent	35
Tumor variables
Site (single/multiple)	154/38
Organ (pulmonary/extrapulmonary)	164/62
Treatment variables
Surgery (yes/no) (unknown = 10)	90/92 (47 %)
Chemotherapy (yes/no) (unknown = 7)	172/13 (90 %)
Outcome variables
Median follow-up (years, SD)	2.7 (2.6)
Median follow-up for survivors (years, SD)	4.6 (3.1)
Disease-specific survival
1 year	89 %
5 years	30 %
10 years	15 %

HRT hormone replacement therapy